PCK Tri-Axis Dominant-Primary Series IV-AG

Brassica nigra

Black Mustard

Tier IVPCK Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Sharp-dominant tri-axis C+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01291

Genomic Edits

GC Content

49.1%

Construct Length

6,057 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPA1 + TRPM8 + CaSR

IFI Score

238

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PCK pathway operation
Cross-pathway regulatory circuit for sharp-dominant PCK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and CaSR pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PCK) with cross-pathway flux managementT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier IV PCK triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities